Fos B is a member of the Fos family of transcription factors, which also includes c-Fos, Fra-1, and Fra-2. These proteins dimerize with members of the Jun family to form the activator protein-1 (AP-1) complex, a key transcriptional regulator involved in a myriad of cellular processes, including cell proliferation, differentiation, and survival. The Fos proteins are characterized by a basic leucine zipper domain that enables their dimerization with Jun proteins. Among the Fos proteins, Fos B holds a unique position due to the existence of its truncated version, ΔFos B, which arises from alternative splicing. ΔFos B has a longer half-life compared to full-length Fos B, leading to its persistent expression in cells and sustained modulation of target genes. The balanced expression and activity of Fos B are essential for cellular homeostasis, as disruptions can have implications for various physiological and pathological processes.
Fos B inhibitors are a class of chemical compounds designed to specifically target and modulate the activity or expression of Fos B. These inhibitors can operate through a range of mechanisms. Some might bind directly to Fos B or its dimerization partners, preventing the formation of the AP-1 complex and thereby inhibiting its transcriptional activity. Others might interfere with the signaling pathways that regulate the expression or post-translational modifications of Fos B, affecting its levels or activity in the cell. Additionally, some inhibitors might be tailored to block the alternative splicing events that give rise to ΔFos B, modulating the balance between full-length Fos B and its truncated variant.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SR 11302 | 160162-42-5 | sc-204295 | 10 mg | $350.00 | 28 | |
SR 11302 is a potent AP-1 inhibitor, which directly targets the AP-1 complex. By inhibiting AP-1, Fos B activity is reduced. | ||||||
Tanshinone IIA | 568-72-9 | sc-200932 sc-200932A | 5 mg 25 mg | $86.00 $310.00 | 22 | |
Tanshinone IIA inhibits AP-1 activation, thereby inhibiting Fos B's transcriptional activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin inhibits the activation of AP-1, of which Fos B is a component, thus suppressing its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is an inhibitor of MEK, an upstream activator of AP-1. By inhibiting MEK, Fos B-mediated AP-1 activity is reduced. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which is upstream of AP-1. This leads to reduced activation of Fos B and AP-1. | ||||||
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $107.00 $376.00 $2147.00 | 3 | |
Nordihydroguaiaretic acid suppresses AP-1 activation, reducing the transcriptional activity of Fos B. | ||||||
Plumbagin | 481-42-5 | sc-253283 sc-253283A | 100 mg 250 mg | $51.00 $61.00 | 6 | |
Plumbagin is known to inhibit AP-1 activation, suppressing the activity of its components, including Fos B. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $94.00 $173.00 $255.00 $423.00 | 26 | |
Capsaicin can suppress AP-1 activation, thus inhibiting the transcriptional activity of Fos B. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin inhibits AP-1 activity, reducing the transcriptional activity of Fos B within the complex. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein can reduce AP-1 activation, subsequently inhibiting Fos B's transcriptional activity. | ||||||